-
-
-
-
-
-
-
Tandem Diabetes Care (TNDM) PT Raised to $22 at Mizuho
-
-
-
-
-
-
-
Tandem Diabetes gets FDA clearance for Android app
-
-
-
-
-
-
-
Citi Upgrades Tandem Diabetes Care (TNDM) to Neutral
-
-
-
-
-
-
-
Piper Sandler's Key MedTech Takeaways From ADA 2025
-
-
-
-
-
-
-
Tandem Diabetes (TNDM) Misses Q1 EPS by 137c, provides guidance
-
-
-
-
-
-
-
Bernstein SocGen Group Downgrades Tandem Diabetes Care (TNDM) to Market Perform
-
-
-
-
-
-
-
Tandem Diabetes Care (TNDM) PT Lowered to $40 at TD Cowen
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

